BackgroundLate-life depression may increase the risk of incident dementia, in particular of
Alzheimer's disease and vascular dementia.AimsTo conduct a systematic review and meta-…

BackgroundTwo recent clinical studies support the feasibility of trials to evaluate the disease-modifying
properties of lithium in Alzheimer's disease, although no benefits were obtained …

Objective: Bipolar disorder (BD) is common in clinical psychiatric practice, and several
studies have estimated its prevalence to range from 0.5 to 5% in community-based samples. …

Objective There is a long‐standing debate in the literature whether depressive symptoms
increase the risk of dementia in older with mild cognitive impairment (MCI). We aim to conduct …

The identification of biological markers at early stages of Alzheimer's disease (AD)
contributes to diagnostic accuracy and adds prognostic value. However, in spite of recent …

Background Vascular depression is regarded as a subtype of late-life depression characterized
by a distinct clinical presentation and an association with cerebrovascular damage. …

In view of the growing prevalence of Alzheimer's disease (AD) worldwide, there is an urgent
need for the development of better diagnostic tools and more effective therapeutic …

Lithium salts have a well-established role in the treatment of major affective disorders. More
recently, experimental and clinical studies have provided evidence that lithium may also …

Adiponectin, an adipocytokine released by the adipose tissue and has important roles in the
metabolic regulation and inflammatory control, may play an important roles in the …

Recent morphometric MRI studies have investigated brain volume abnormalities associated
with the diagnosis of Alzheimer’s disease (AD) using voxel-based morphometry (VBM). This …